Clinical Trials Logo

Cognitive Change clinical trials

View clinical trials related to Cognitive Change.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT05921084 Active, not recruiting - Stroke Clinical Trials

MIND Diet to Improve Cognitive Function in Mild Stroke Patients

MINDICOMS
Start date: July 23, 2023
Phase: N/A
Study type: Interventional

A 6-month pilot randomized controlled trial designed to test the effect of the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet + usual medical care versus usual medical care on the rate of cognitive change and several other secondary outcomes through a randomized controlled trial in 60 mild stroke patients aged 35-70 years without dementia.

NCT ID: NCT05879562 Active, not recruiting - Clinical trials for Cognitive Impairment

Validation of a Digital Self-Administered Cognitive Screening Tool: MoCA-XpressO

MoCA
Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The investigators conducted a validation study for the Montreal Cognitive Assessment (MoCA)-XpressO compared to the digital-MoCA test (version 8.1) as the gold standard. Participants were recruited from the MoCA clinic and a family practice. Ethics approval was received, and all participants provided informed consent. A crossover study design was applied to the MoCA-XpressO and the digital-MoCA test; participants were randomized for the order of administration. The investigators only recruited participants who did not complete a MoCA test during the 3 months prior to the study. A logistic regression model was built, and the accuracy of the model was evaluated by the sensitivity, specificity, and area under the Receiver Operating Characteristic (ROC) curve.

NCT ID: NCT05353790 Active, not recruiting - Cognitive Change Clinical Trials

Dietary Exchanges With Avocado and Mango in Pre-diabetes

AVMa
Start date: October 11, 2021
Phase: N/A
Study type: Interventional

The research is designed as a randomized, 2-arm, parallel, controlled, human clinical trial to investigate the effects of avocado and mango consumption for 8 weeks on indices of macro- and micro- vascular function in individuals with prediabetes. FMD of the brachial artery, pulse wave velocity (PWV), central blood pressure (cBP), and Optical Coherence Tomography Angiography (OCTA) of the eye will be used for vascular assessments. The research plan will also explore cognitive and kidney function benefits of regular avocado and mango intake using specified cognitive tasks and kidney function biomarkers

NCT ID: NCT05347966 Active, not recruiting - Clinical trials for Mild Cognitive Impairment

Brain Health Support Program

CTU: BHSP
Start date: April 6, 2022
Phase: N/A
Study type: Interventional

The Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia (CAN-THUMBS UP, or CTU) is a comprehensive and innovative program aimed to develop, implement and evaluate an interactive and compelling online educational Brain Health Support Program (BHSP) intervention, called Brain Health PRO (BHPro), with potential to positively influence dementia literacy, lifestyle risk factors, and scale-up to reach the broader Canadian public; enroll and retain a community-dwelling Platform Trial Cohort (PTC) of individuals at risk of dementia; and support an open platform trial to test a variety of multidomain interventions that might further benefit individuals at risk of dementia.

NCT ID: NCT05314647 Active, not recruiting - Cognitive Change Clinical Trials

Lutein Supplementation in Healthy Children

Start date: July 15, 2023
Phase: N/A
Study type: Interventional

This is a single site, randomized, double-blind placebo controlled parallel arm study assessing the effects of 6 months lutein supplementation on cognitive and visual outcomes in healthy children exposed to excessive digital screen time.

NCT ID: NCT05229705 Active, not recruiting - Cognitive Change Clinical Trials

Exercise in Older Adults at Risk for Type 2 Diabetes

Start date: September 23, 2022
Phase: N/A
Study type: Interventional

Older adults with type 2 diabetes experience neurocognitive decline and are at higher risk for developing dementia. Consequently, older adults at-risk for developing type 2 diabetes (i.e., those who are overweight and/or prediabetic) are at higher risk for neurocognitive decline, and intervening at this point may prevent or delay the onset of such decline. One promising lifestyle intervention that has been shown to improve cognitive function and brain health in other populations is resistance exercise. We previously conducted a 6-month resistance training randomized controlled trial (RCT) pilot study that showed a large scale trial would be viable and feasible. Consequently, we would like to explore resistance exercise as a lifestyle intervention to improve cognition and brain structure in older adults at risk for diabetes.

NCT ID: NCT05143294 Active, not recruiting - Child Development Clinical Trials

Conectar Jugando: Board Games in Elementary Classrooms (6-12 Years Old) to Improve Executive Functions

CJ-Aula
Start date: September 30, 2021
Phase: N/A
Study type: Interventional

Executive functions are cognitive processes that have been frequently related to adequate academic performance in the scientific literature. Current research aimed at training executive functions has found promising results using the modern board game as a cognitive tool in children. Considering the growing interest of teachers in this playful and possibly educational and cognitive resource, a game program for cognitive purposes has been designed to be used in primary classrooms. The main objective of the present study is to test the efficacy of a cognitive training program in the classroom based on modern board games in primary school students from ordinary schools (6 to 12 years old). For this, there will be an experimental group that will carry out the game program "Conectar Jugando" in the classroom implemented by the teachers of the participating centers, and a control group that will be on standby and will be compensated by carrying out the game program at the finalize the post-intervention evaluation. The classes of each school stage will be randomly assigned to an experimental group and a passive control group in each of the participating schools.

NCT ID: NCT04058431 Active, not recruiting - Clinical trials for Musculoskeletal Pain

Osteopathic Manipulation Makes a Neuropsychological Difference

BOD
Start date: January 2017
Phase: N/A
Study type: Interventional

Patients with pain commonly experience cognitive impairment. While symptoms of pain are effectively treated with osteopathic manipulative treatment (OMT), the cognitive piece is vastly ignored. Pain-induced cognitive dysfunction can be severe and is particularly apparent in working memory and attention. There is good reason to also expect cognitive responsiveness to OMT. Previous research has already reported related psychiatric outcomes, including relief from stress, self-perception and anxiety, suggesting that OMT may produce more global effects on cortical processing than currently thought.

NCT ID: NCT04051918 Active, not recruiting - Aging Clinical Trials

Robot-assisted Cognitive Training for Lonely Older Adults With Mild Cognitive Impairment (MCI)

MCI
Start date: October 7, 2021
Phase: N/A
Study type: Interventional

This study will use a socially assistive robot to deliver cognitive training in the form of a music (piano) learning intervention to socially isolated older adults with mild cognitive impairment.

NCT ID: NCT03875131 Active, not recruiting - Cognitive Change Clinical Trials

Definition, Quantification, and Utility of Biomarkers of Repetitive Brain Injury in Predicting Concussion and Other Long-Term Injury Risks in Patients With Atrial Fibrillation (Concussion AF)

Concussion AF
Start date: July 15, 2017
Phase:
Study type: Observational

This is a prospective clinical study designed to evaluate biomarkers of brain injury and dementia incidence and moderate cognitive decline rates in moderate- to high-risk atrial fibrillation patients that undergo standard of care atrial fibrillation management.